News

Red Violet Inc Sets Date for Earnings Call in Q2 2025

Red Violet Inc Sets Date for Earnings Call in Q2 2025

Red Violet Inc Earnings Announcement

Red Violet, Inc. (NASDAQ: RDVT), an innovative analytics and information solutions provider, has announced that it will release its financial results for the second quarter closing on June 30, 2025. This announcement comes as the company prepares to share its insights with stakeholders and the investment community.

Key Details of the Earnings Call

The financial results will be issued after the U.S. financial markets conclude on a specific Wednesday. In addition to the results, Red Violet Inc will be hosting an earnings call at 4:30 PM ET to discuss their quarterly performance and significant updates on business developments.

How to Access the Earnings Call

Participants interested in joining the call must register beforehand. This ensures that everyone receives unique dial-in numbers, as a general dial-in number will not be distributed. It’s important to log in at least 15 minutes early to accommodate any necessary downloads related to the call.

Webcast and Registration Information

The earnings call will be simultaneously webcast, providing an accessible means for attendees to join. Interested parties can find the registration links on Red Violet's official website. Be sure to check the Investors section to access the webcast url and gather all relevant details.

Post-Call Availability

After completing the earnings conference, an archived webcast will be made available for those who need to revisit the discussions or missed the live event. This is beneficial for stakeholders wanting a comprehensive understanding of the quarterly earnings and the company’s direction.

About Red Violet, Inc.

Red Violet prides itself on developing proprietary technologies that enhance its analytical capabilities to provide identity intelligence. Their innovative solutions empower organizations at various scales, allowing them to operate more confidently in their respective markets. By enabling real-time identification and location tracking of individuals, businesses, and assets, Red Violet contributes to a range of applications from risk mitigation to fraud detection.

Significance of CORE™ Platform

The firm’s flagship platform, CORE™, has been designed specifically for enterprise use while also being scalable for smaller organizations. It adeptly transforms vast datasets into actionable intelligence, paving the way for companies to achieve frictionless commerce while maintaining safety standards and combating fraud effectively.

Company Culture and Values

Red Violet is dedicated to harnessing analytics to shape the future. The company fosters a culture of innovation and collaboration, ensuring that every solution is not only effective but also tailored to meet specific client needs. Their commitment to value creation resonates across various domains, which is critical in today’s fast-paced business environment.

Contact Information

If you have questions or require further information, reach out to Camilo Ramirez at Red Violet, Inc., or Steven Hooser from Three Part Advisors. They are available to provide insights into the company’s performance and address investor queries.

Frequently Asked Questions

When will Red Violet release its Q2 2025 earnings?

Red Violet will release its Q2 2025 earnings on Wednesday, August 6, 2025, after market close.

What time is the earnings call scheduled?

The earnings call is scheduled for 4:30 PM ET on the same day.

Where can I find the webcast of the earnings call?

The webcast will be available on Red Violet's official website under the Investors section.

Do participants need to register for the call?

Yes, participants must register to receive unique dial-in credentials.

What is Red Violet's focus in the analytics sector?

Red Violet specializes in identity intelligence, utilizing advanced technologies to offer solutions like fraud detection and risk management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 487

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 46

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 347

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 56

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 62

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

EssilorLuxottica Reports Share Capital and Voting Rights Update

Updated Category News Views 214

Overview of EssilorLuxottica's Share Capital EssilorLuxottica, a prominent global leader in eyewear design, manufacture, and distribution, provides a detailed disclosure of its outstanding share capital and voting rights as of a recent date. This information is essential for shareholders and market watchers to understand the company's governance and share structure. Share...

Continue Reading
WM Technology, Inc. Faces Class Action Lawsuit with SEC Fallout

Updated Category News Views 208

WM Technology, Inc. Faces Legal Challenges Recently, a class action lawsuit has arisen against WM Technology, Inc. (NASDAQ: MAPS), a pivotal player in the online cannabis marketplace. The Pomerantz Law Firm has initiated this legal action on behalf of affected investors. As the case unfolds, individuals who believe they have been impacted by the company's actions are...

Continue Reading
EVgo Targets 2026 for Profitable Future Amid Challenges

Updated Category News Views 554

EVgo Overview EVgo Inc. (NASDAQ: EVGO) has faced recent fluctuations in share price following the announcement of its fiscal third-quarter results. The company operates one of the largest public electric vehicle charging networks in the United States, and it has been navigating a challenging landscape in the EV sector. Financial Performance Analysis In its latest report,...

Continue Reading
CNX Resources Corporation Reveals Financial Updates and Call Schedule

Updated Category News Views 126

CNX Resources Corporation Financial Results Announcement CNX Resources Corporation (NYSE: CNX) is set to unveil its financial results for the fourth quarter of 2025. This important event will take place at 6:45 a.m. Eastern Time on an upcoming Thursday. During this announcement, CNX intends to release a concise press statement that will include essential documents linking...

Continue Reading
Nvidia's Revolutionary AI Dominance and Future Outlook

Updated Category News Views 193

Understanding AI and Nvidia's Impact Since the dawn of the internet, investors have seen many trends come and go, but few have been as impactful as the artificial intelligence (AI) revolution. This groundbreaking technology has sparked interest among both seasoned professionals and everyday investors, all eager to explore its immense potential. It’s estimated that AI...

Continue Reading